Compile Data Set for Download or QSAR
Report error Found 121 Enz. Inhib. hit(s) with all data for entry = 12804
TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729716BDBM729716((2R)-2-amino-3-(7-chloro-4-{[(furan- 2-yl)methyl]a...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729717BDBM729717(6-[(2S)-2-aminopropyl]-3-fluoro-7- methyl-N-[(thio...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729714BDBM729714((2R)-2-amino-3-(7-bromo-4- {[(thiophen-2- yl)methy...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729715BDBM729715((2R)-2-amino-3-(7-bromo-4-{[(furan- 2-yl)methyl]am...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729726BDBM729726(6-[(2R,3S)-2-amino-3-fluorobutyl]-7- methyl-N-[(th...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729631BDBM729631(6-[(2S)-2-aminopropyl]-7-methyl-N- [(thiophen-2-yl...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729660BDBM729660(6-[(2S)-2-aminopropyl]-7-bromo-N- [(thiophen-2-yl)...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729725BDBM729725(6-[(2S)-2-aminopropyl]-7-(prop-1-yn- 1-yl)-N-[(thi...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729661BDBM729661(6-[(2S)-2-aminopropyl]-7-chloro-N- [(thiophen-2-yl...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729720BDBM729720(6-[(2S)-2-aminopropyl]-7-bromo-N- [(furan-2-y1)met...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729721BDBM729721(6-[(2S)-2-aminopropyl]-7-chloro-N- [(furan-2-yl)me...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729732BDBM729732(6-[(2S)-2-aminopropyl]-7-ethynyl-N- [(thiophen-2-y...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729731BDBM729731(6-[(2S)-2-aminopropyl]-7-ethynyl-N- [(furan-2-y1)m...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729742BDBM729742(6-[(2R,3S)-2-amino-3-fluorobutyl]-7- bromo-N-[(thi...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729711BDBM729711((2R)-2-amino-3-(7-chloro-4- {[(thiophen-2- yl)meth...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729743BDBM729743(6-[(2R)-2-amino-3-methoxypropyl]-7- bromo-N-[(thio...)
Affinity DataIC50: 300nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729654BDBM729654((3S)-3-amino-4-(4-{[(furan-2- yl)methyl]amino}-7-m...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729655BDBM729655(6-[(2R)-2-amino-3- (methylsulfanyl)propyl]-N-[(fur...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729713BDBM729713(6-[2-amino-2-(oxetan-3-yl)ethyl]-7- methyl-N-[(thi...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729649BDBM729649(6-[(2S)-2-aminopropyl]-4-{[(thiophen- 2-yl)methyl]...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729727BDBM729727(6-[(2R,3R)-2-amino-3-fluorobutyl]-7- methyl-N-[(th...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729656BDBM729656(6-[(2S)-2-amino-4-fluorobutyl]-N- [(furan-2-yl)met...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729637BDBM729637(6-[(2S)-2-aminopropyl]-N-[(3- fluorothiophen-2-yl)...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729634BDBM729634((2R)-2-amino-3-(7-methyl-4- {[(thiophen-3- yl)meth...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729635BDBM729635(6-[(2S)-2-aminopropyl]-7-methyl-N- [(thiophen-3-yl...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729633BDBM729633(6-[(2S)-2-aminopropyl]-7-methyl-N- [(1,3-thiazol-2...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729647BDBM729647(6-[(2S)-2-aminopropyl]-7-methoxy-N- [(thiophen-2-y...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729704BDBM729704(6-[(2S)-2-aminopropyl]-7-cyclopropyl- N-[(thiophen...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729640BDBM729640(6-[(2S)-2-aminopropyl]-7-methyl-N- [(1H-pyrazol-1-...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729641BDBM729641(6-[(2S)-2-aminopropyl]-N-[(5- fluorothiophen-2-yl)...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729748BDBM729748(US20250101034, Compound 142)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729685BDBM729685((3S)-3-amino-4-(7-methyl-4- {[(thiophen-2- yl)meth...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729746BDBM729746(6-[(2S)-2-amino-1,1-difluoropropyl]-7- bromo-N-[(t...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729682BDBM729682(6-[(2R)-2-amino-3- (methylsulfanyl)propyl]-7-methy...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729747BDBM729747(6-(2-amino-3-fluoropropyl)-7-methyl- N-[(thiophen-...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729744BDBM729744(6-[(2R)-2-amino-3- cyclopropoxypropyl]-7-bromo-N- ...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729745BDBM729745(US20250101034, Compound 139)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729630BDBM729630((2R)-2-amino-3-(7-methyl-4- {[(thiophen-2- yl)meth...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729628BDBM729628((2R)-2-amino-3-(4-{[(furan-2- yl)methyl]amino}-7-m...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729692BDBM729692(6-[(2S)-2-amino-3-cyclopropylpropyl]- 7-methyl-N-[...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729629BDBM729629(6-[(2S)-2-aminopropyl]-N-[(furan-2- yl)methyl]-7-m...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729734BDBM729734(6-[(2S)-2-amino-1,1-difluoropropyl]-7- methyl-N-[(...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729670BDBM729670(6-[(2S)-2-aminopropyl]-N-[(4- fluorothiophen-2-yl)...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729664BDBM729664(6-[(2S)-2-aminopropyl]-N-[(thiophen- 2-yl)methyl]t...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729679BDBM729679(6-[(2S)-2-amino-1-fluoropropyl]-7- methyl-N-[(thio...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729676BDBM729676(6-[(2S)-2-amino-3-cyclopropylpropyl]- N-[(furan-2-...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729741BDBM729741(6-[(2R)-2-amino-3- (difluoromethoxy)propyl]-7-meth...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729677BDBM729677((2R)-2-amino-3-(4-{[(thiophen-2- yl)methyl]amino}t...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729738BDBM729738(6-[(2R)-2-amino-3-[(1R)-2,2- difluorocyclopropyl]p...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetAtaxin-3(Mouse)
Skyhawk Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 729674BDBM729674(6-[(2S)-2-amino-4,4,4-trifluorobutyl]- 7-methyl-N-...)
Affinity DataIC50: 2.75E+3nMAssay Description:ATXN3 protein levels were assessed by Mesoscale Discovery (MSD) assay developed with one pair of anti-ATXN3 antibodies. The capture and detect antibo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

Displayed 1 to 50 (of 121 total ) | Next | Last >>
Jump to: